82 related articles for article (PubMed ID: 22433908)
1. Immunomodulation of memory-impairing protein tau in Alzheimer's disease.
Zilka N; Stozicka Z; Cente M; Kazmerova Z; Kovacech B; Novak M
Neurodegener Dis; 2012; 10(1-4):242-5. PubMed ID: 22433908
[TBL] [Abstract][Full Text] [Related]
2. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
[TBL] [Abstract][Full Text] [Related]
3. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
5. Of rodents and men: the mysterious interneuronal pilgrimage of misfolded protein tau in Alzheimer’s disease.
Levarska L; Zilka N; Jadhav S; Neradil P; Novak M
J Alzheimers Dis; 2013; 37(3):569-77. PubMed ID: 23948940
[TBL] [Abstract][Full Text] [Related]
6. First transgenic rat model developing progressive cortical neurofibrillary tangles.
Filipcik P; Zilka N; Bugos O; Kucerak J; Koson P; Novak P; Novak M
Neurobiol Aging; 2012 Jul; 33(7):1448-56. PubMed ID: 21196063
[TBL] [Abstract][Full Text] [Related]
7. Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy.
Zilka N; Stozicka Z; Kovac A; Pilipcinec E; Bugos O; Novak M
J Neuroimmunol; 2009 Apr; 209(1-2):16-25. PubMed ID: 19232747
[TBL] [Abstract][Full Text] [Related]
8. Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats.
Hrnkova M; Zilka N; Minichova Z; Koson P; Novak M
Brain Res; 2007 Jan; 1130(1):206-13. PubMed ID: 17169350
[TBL] [Abstract][Full Text] [Related]
9. Stress-induced activation of the sympathoadrenal system is determined by genetic background in rat models of tauopathy.
Lejavova K; Ondicova K; Horvathova L; Hegedusova N; Cubinkova V; Vargovic P; Manz G; Filipcik P; Mravec B; Novak M; Kvetnansky R
J Alzheimers Dis; 2015; 43(4):1157-61. PubMed ID: 25147110
[TBL] [Abstract][Full Text] [Related]
10. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
11. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
Eriksen JL; Janus CG
Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of memory loss in Abeta and tau mouse models.
Ashe KH
Biochem Soc Trans; 2005 Aug; 33(Pt 4):591-4. PubMed ID: 16042551
[TBL] [Abstract][Full Text] [Related]
14. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
15. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
Cente M; Filipcik P; Pevalova M; Novak M
Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
[TBL] [Abstract][Full Text] [Related]
16. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
[TBL] [Abstract][Full Text] [Related]
17. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
18. Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17.
Giustiniani J; Sineus M; Sardin E; Dounane O; Panchal M; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE
J Alzheimers Dis; 2012; 29(2):471-83. PubMed ID: 22233767
[TBL] [Abstract][Full Text] [Related]
19. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
20. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]